SEC Form 4 · accession 0000921895-17-001341
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Viraj J Patel
Officer — Chief Financial Officer
Period of report
May 4, 2017
Accepted (ET)
May 8, 2017 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy)F1 | $6.59 | May 4, 2017 | A | 75,000 | A | May 4, 2018 | May 4, 2022 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1The Option vests as follows: (a) as to 25,000 shares of common stock of the Issuer ("Stock), on May 4, 2018, (b) as to a further 25,000 shares of Stock, on May 4, 2019, and (c) as to the remaining 25,000 shares of Stock, on May 4, 2020.